Europe — EMA

Padviram (Emtricitabine, Efavirenz, Tenofovir Disoproxil Succinate)

Emtricitabine, Efavirenz, Tenofovir Disoproxil Succinate

Request sourcing

Pack/s

What is Emtricitabine, Efavirenz, Tenofovir Disoproxil Succinate?

Emtricitabine, the active ingredient in Padviram, is a nucleoside reverse transcriptase inhibitor presented as a fixed-dose combination tablet for oral use. It treats HIV-1 infection in adults and adolescents. GNH USA supplies Padviram as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Padviram as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

What is Emtricitabine, Efavirenz, Tenofovir Disoproxil Succinate used for?

Padviram combines three antiretroviral agents that act on the HIV replication cycle.

- HIV-1 infection (adults): Improves virologic suppression and reduces the risk of disease progression. - HIV-1 infection (adolesc ). ... .... .... .... .... ... .... ... … ...... .... ... … ... ... ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →